echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Interferon signal suppression, will not interfere with Parkinson's disease risk or age of onset

    Neurology: Interferon signal suppression, will not interfere with Parkinson's disease risk or age of onset

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Peripheral inflammation is presumed to be one of the causes of Parkinson's disease (PD), especially when it exists in the gastrointestinal tract.


    Currently, many types of TNF inhibitors have been approved for the treatment of systemic inflammatory diseases, including inflammatory bowel disease (IBD).


    Mendelian randomization is a valuable method to help answer questions in drug epidemiology.


    Due to the principle of Mendelian randomization, the association between this genetic variation and disease is not expected to produce confounding or reverse causality, thus facilitating causal inference.


    prevention

    In order to evaluate the effect of long-term tumor necrosis factor (TNF) inhibition on Parkinson's disease (PD) risk and age of onset, they conducted a 2-sample Mendelian randomized study using genome-wide association studies ( GWAS ) summary statistics.


    GWAS

    The genetic association with lower circulating C-reactive protein (CRP; GWAS n = 204,402) has determined the genetic variation near the gene encoding TNF receptor 1 (TNFR1) (TNFRSF1A), predicting that anti-TNF therapy drugs block TNFR1 signaling Sex.


    They used International Parkinson's Disease Genomics Consortium and 23andMe's GWAS data to estimate the impact of TNF-TNFR1 inhibition on PD risk (ncases/controls = 37,688/981,372) and age of PD onset (n = 28,568).


    medsci.


    TNF-TNFR1 signal inhibition is not expected to affect the risk of PD or the age of onset.


    The findings are consistent in different models using different genetic tools and Mendelian randomization estimators.


    Original source:

    https://n.








    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.